Webinars on IMI2 - Call 13

Start Date 27/11/2017 End Date 16/01/2018

IMI will hold webinars on IMI2 – Call 13 from 27 November 2017 to Tuesday 16 January 2018 inclusive.

All webinars on the Call topics will feature a presentation by the EFPIA topic coordinator and time for questions and answers. The webinars represent an excellent opportunity to learn more about the Call topics, interact directly with the topic coordinators, and get in touch with potential project partners.

The webinar on IMI’s rules and procedures will include presentations of IMI's intellectual property policy and tips on the preparation of proposal submissions. IMI will also hold a dedicated webinar for small and medium-sized enterprises (SMEs). This will cover elements of the different Call topics that may be of particular relevance for SMEs, as well as a presentation of IMI’s rules and procedures with a focus on aspects that are most important for SMEs.

The slides presented will be published here, along with recordings of all webinars.

Practical points

Registration is free but obligatory via the links given for each webinar. When you register, you will receive an automatic confirmation e-mail with your own personal web link and dial-in number which you should use on the day.

We use GoToWebinar for our webinars. You can check your computer is compatible with GoToWebinar here.

All times given are Brussels time (Central European Time, CET).

The full Call text and details of how to apply can be found on the IMI2 - Call 13 page.

Schedule

IMI rules & procedures

Opportunities for SMEs in IMI2 – Call 13

Topic-specific webinars

Support and coordination action for the projects of the neurodegeneration area of the Innovative Medicines Initiative
Monday 27 November, 15:00 - 16:30
Download the presentation | Watch the webinar online

Human tumour microenvironment immunoprofiling
Friday 1 December, 10:30 - 12:00
Download the presentation | Watch the webinar online
Note on the recording: Although the presentation of the topic is complete, technical problems meant we were unable to hold the questions and answers (Q&A) session at the end. A second webinar, for the Q&A session only, will be held on Monday 18 December at 10:30. Register here.

Mitochondrial dysfunction in neurodegeneration
Monday 4 December, 10:30 - 12:00
Download the presentation | Watch the webinar online

Translational safety biomarker pipeline (TRANSBIOLINE): enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease
Monday 4 December, 15:00 - 16:30
Download the presentation | Watch the webinar online

Pilot programme on a clinical compound bank for repurposing. This programme includes the following topics: cardiovascular diseases and diabetes; respiratory diseases; neurodegenerative diseases; rare/orphan diseases
Wednesday 6 December, 10:30 - 12:00
Download the presentation | Watch the webinar online

A sustainable European induced pluripotent stem cell platform
Monday 11 December, 10:30 - 12:00
Download the presentation | Watch the webinar online

CONCEPTION – continuum of evidence from pregnancy exposures, reproductive toxicology and breastfeeding to improve outcomes now
Monday 11 December, 15:00 - 16:30
Download the presentation | Watch the webinar online

Improving the preclinical prediction of adverse effects of pharmaceuticals on the nervous system
Tuesday 12 December, 15:00 - 16:30
Register

Linking digital assessment of mobility to clinical endpoints to drive regulatory acceptance and clinical practice
Thursday 14 December, 10:30 - 12:00
Register

Assessment of the uniqueness of diabetic cardiomyopathy relative to other forms of heart failure using unbiased pheno-mapping approaches
Thursday 14 December, 15:00 - 16:30
Register

The value of diagnostics to combat antimicrobial resistance by optimising antibiotic use
Friday 15 December, 10:30 - 12:00
Register

Genome-environment interactions in inflammatory skin disease
Friday 15 December, 15:00 - 16:30
Register

Federated and privacy-preserving machine learning in support of drug discovery
Tuesday 5 December, 10:30 - 12:00 -
Webinar cancelled as topic withdrawn from Call

Data protection

IMI2 Joint Undertaking is committed to user privacy. The policy governing the processing of personal data by institutions and bodies of the European Union is based on Regulation (EC) N° 45/2001 of the European Parliament and of the Council of 18 December 2000. Complete information is available here.